CTRI/2023/01/048716进行中(未招募)未知
Microbiota-directed complementary foods to treat children with moderate acute malnutrition in the first two years of life – Open label Randomized controlled Pre-proof of Concept (MDCF prePOC) study - MDCF prePOC
Christian Medical College (CMC), Vellore0 个研究点目标入组 630 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 630
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •INTERVENTIONAL COHORT:
- •1.Children aged 6-18 months of either gender and no longer exclusively breastfed
- •2.Weight to length Z (WLZ) score <-2 to -3 without bilateral pedal edema at the time of randomization (for MAM children)
- •3.Parent(s) willing for study participation and aid in following study procedures
- •4.Agree to remain in the study area for the study duration
- •HEALTHY COHORT:
- •1. Age between 90 days to 119 days (3 to < 4 months)
- •2. Anthropometric scores (WLZ above -1SD)
- •3. Willing to stay in the study area for 2 years
排除标准
- •INTERVENTIONAL COHORT:
- •1.Any ongoing fever or medical condition persisting for >last 14 days or requires hospitalization
- •2.Any congenital/acquired disorder affecting growth
- •3.History of soy, milk protein or peanut allergy
- •4.Severe pallor on examination
- •5.Antibiotic use (within last 15 days before the onset of intervention)
- •6.Ongoing maternal antibiotic usage for breastfeeding infants
- •7.Receiving concurrent treatment for another condition
- •8.Failure to obtain informed written consent from parents/guardians
- •9.Any other condition that in the opinion of the study investigator serves as an exclusion
- •Note: Criteria No 1, 4, 5,7 will be temporary exclusion criterion, children will be eligible for inclusion if they are not having any medical conditions, severe pallor, antibiotic use on any concurrent treatment for last 15 days from the day of enrolment.
- •HEALTHY COHORT:
- •1. No history of antibiotic consumption in the past 15 days (temporary exclusion)
- •2. History of any medical illness in the past 15 days (temporary exclusion)
- •3. Any medical condition persisting for >last 14 days prior to enrolment or requires hospitalization (temporary exclusion))
研究者
相似试验
Unknown
2 期
SENeGal SYNbiotic (SENGSYN) StudyPACTR202102689928613iverpool School of Tropical Medicine708
尚未招募
Unknown
Probiotic supplementation in improving symptom control among children with AsthmaCTRI/2023/10/058216DrNiranjan Biswal
已完成
不适用
Effectiveness of probiotics in the treatment of children with chronic abdominal pain and small intestinal bacterial overgrowth. A randomized placebo-controlled trial.small intestinal bacterial overgrowthchronic abdominal pain10018012NL-OMON39168Jeroen Bosch Ziekenhuis15
进行中(未招募)
不适用
Probiotic supplementation in patients with chronic liver disease, resulting from the hepatitis C virusF32B18.2Depressive episodeChronic viral hepatitis CDRKS00007817allemand Health Solutions, Institute Rosell Inc.12
进行中(未招募)
不适用
Effect of Mediterranean diet components on microbiotaNutritional, Metabolic, EndocrineOverweight and low adherence to the Mediterranean DietISRCTN20979777Ministry of Education, Universities and Research125
